Real-World Kidney and Glycaemic Outcomes Following Semaglutide Initiation in Adults with Type 2 Diabetes and Mild Chronic Kidney Disease. [PDF]
Rabbani SA +7 more
europepmc +1 more source
Risk factor obesity: treatment standard. [PDF]
Mashayekhi M +10 more
europepmc +1 more source
Renal Effects of Glucagon-like Peptide-1 Receptor Agonists in Diabetic Kidney Disease: A Narrative Review of Mechanisms and Clinical Evidence. [PDF]
Braha A, Timar B, Sturza A, Timar R.
europepmc +1 more source
Comparison between liraglutide and dulaglutide on the incidence or progression of eye and kidney complications. [PDF]
Katamine A +4 more
europepmc +1 more source
Impact of Albuminuria-Lowering Treatments on Cardiovascular Predictive Ceramides in Diabetes: Post Hoc Analysis of the ROTATE Trials. [PDF]
Pigsborg K +10 more
europepmc +1 more source
Multiple myeloma with spinal involvement: Renal dysfunction and albuminuria are associated with progressive sarcopenia in a longitudinal CT morphometric study. [PDF]
Kylies J +6 more
europepmc +1 more source
Early Post-Discharge Albuminuria Trajectory and Clinical Outcomes After Acute Heart Failure. [PDF]
Galván-Ruiz M +15 more
europepmc +1 more source
Psoriasis and chronic kidney disease: a systemic inflammatory link and a practical kidney assessment pathway. [PDF]
Almeida-Silva G +6 more
europepmc +1 more source
Renal Functional Reserve-Informed Personalized Renoprotection in Chronic Kidney Disease: A Proposed Extension of the KDIGO CGA Framework. [PDF]
Ivanov DD +3 more
europepmc +1 more source
Multiple metabolic factors and kidney dysfunction: Causal evidence and translational insights from a mendelian randomization study. [PDF]
Tong M, Chen C, Pan Y.
europepmc +1 more source

